Clinical burden of obstructive hypertrophic cardiomyopathy in France
BackgroundHypertrophic cardiomyopathy (HCM) can be genetic and occurs as obstructive and non-obstructive 21 subtypes. Little is known about the clinical burden of the obstructive subtype of HCM at a national 22 level, and how it may differ by New York Heart Association (NYHA) class. Therefore, this...
Saved in:
Main Authors: | Philippe Charron, Carla Zema, François-Emery Cotté, Eléonore Herquelot, Taryn Krause, Florent Daydé, Jean-Noël Trochu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1458410/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy
by: B.M. Todurov, et al.
Published: (2020-12-01) -
Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
by: LIN Shuantong, et al.
Published: (2025-01-01) -
Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm
by: N.D. Oryshchyn, et al.
Published: (2016-11-01) -
Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy
by: Minjeong Kim, et al.
Published: (2025-01-01) -
Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies
by: Sevak Hatamian, et al.
Published: (2025-06-01)